Laser Therapy in Managing Vaginal Prolapse

Management of Vaginal Prolapse Using Laser Therapy: Randomized Controlled Trial

Efficacy of laser therapy in postmenopausal women with symptomatic prolapse stage >1. Assessment tools will include prolapse stage quantification system (POP-Q) and validated condition related questionnaires.

Postmenopausal women with symptomatic cystocele and/or rectocele stage 2 or 3 will be 1:1 randomly allocated to Er:YAG laser or watchful waiting group. Participants in the Er:YAG laser group will receive laser therapies at monthly intervals, while participants in the watchful waiting group will receive no treatment. All outcomes in both groups will be evaluated at baseline, 4-months and 6-months from baseline.

Inclusion Criteria:

• Symptomatic prolapse stage >1 (cystocele, vaginal vault prolapse, enterocele, rectocele) according to POP-Q System
• Negative Pap-smear

Exclusion Criteria:

• Asymptomatic prolapse
• prolapse stage <=1
• prolapse of uterus
• presence of any type of genital infections (i.e herpes, vaginitis etc)
• vaginal bleeding
• underlying pathologies that could interfere in patients compliance (i.e psychiatric)